Relay Therapeutics Inc (RLAY)

R&D Expense Growth

8.39%

Quarterly · Period ending:

RLAY logo

RLAY R&D Expense Growth

Latest reported8.39%
RLAY Quarterly R&D Growth (QoQ) (0.00% → 8.39%)
High-resolution chart · PNG

RLAY r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Relay Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
8.3897%
27.3356%
-18.8201%
6.8313%
-13.4293%
8.4231%
-11.1513%
-16.7112%
11.6367%
6.3319%
-4.9059%
-7.6042%
6.4882%
23.1134%
0.5635%
10.5584%
17.1173%
-0.4624%
15.4156%
-73.2532%
449.1052%
-2.5243%
28.8768%
12.5081%
-0.1567%
-3.1553%
22.7377%
11.3374%
22.9621%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.